Host–rabies virus protein–protein interactions as druggable antiviral targets
- 12 February 2013
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 110 (10), E861-E868
- https://doi.org/10.1073/pnas.1210198110
Abstract
We present an unconventional approach to antiviral drug discovery, which is used to identify potent small molecules against rabies virus. First, we conceptualized viral capsid assembly as occurring via a host-catalyzed biochemical pathway, in contrast to the classical view of capsid formation by self-assembly. This suggested opportunities for antiviral intervention by targeting previously unappreciated catalytic host proteins, which were pursued. Second, we hypothesized these host proteins to be components of heterogeneous, labile, and dynamic multi-subunit assembly machines, not easily isolated by specific target protein-focused methods. This suggested the need to identify active compounds before knowing the precise protein target. A cell-free translation-based small molecule screen was established to recreate the hypothesized interactions involving newly synthesized capsid proteins as host assembly machine substrates. Hits from the screen were validated by efficacy against infectious rabies virus in mammalian cell culture. Used as affinity ligands, advanced analogs were shown to bind a set of proteins that effectively reconstituted drug sensitivity in the cell-free screen and included a small but discrete subfraction of cellular ATP-binding cassette family E1 (ABCE1), a host protein previously found essential for HIV capsid formation. Taken together, these studies advance an alternate view of capsid formation (as a host-catalyzed biochemical pathway), a different paradigm for drug discovery (whole pathway screening without knowledge of the target), and suggest the existence of labile assembly machines that can be rendered accessible as next-generation drug targets by the means described.Keywords
This publication has 45 references indexed in Scilit:
- HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assemblyThe Journal of cell biology, 2012
- Distinct Effects of Two HIV-1 Capsid Assembly Inhibitor Families That Bind the Same Site within the N-Terminal Domain of the Viral CA ProteinJournal of Virology, 2012
- Kinetic analysis reveals the ordered coupling of translation termination and ribosome recycling in yeastProceedings of the National Academy of Sciences of the United States of America, 2011
- HIV Gag-Leucine Zipper Chimeras Form ABCE1-Containing Intermediates and RNase-Resistant Immature Capsids Similar to Those Formed by Wild-Type HIV-1 GagJournal of Virology, 2011
- Transient protein-protein interactionsProtein Engineering, Design and Selection, 2011
- Ribosome recycling depends on a mechanistic link between the FeS cluster domain and a conformational switch of the twin-ATPase ABCE1Proceedings of the National Academy of Sciences of the United States of America, 2011
- The Role of ABCE1 in Eukaryotic Posttermination Ribosomal RecyclingMolecular Cell, 2010
- Knockdown Screens to Knockout HIV-1Cell, 2008
- Structure of the Antiviral Assembly Inhibitor CAP-1 Complex with the HIV-1 CA ProteinJournal of Molecular Biology, 2007
- Host ABCE1 is at Plasma Membrane HIV Assembly Sites and Its Dissociation from Gag is Linked to Subsequent Events of Virus ProductionTraffic, 2006